Outcomes of colorectal cancer resection in patients with inflammatory bowel disease: a national population-based analysis in England and Wales
Kuryba A, Vallance AE, Boyle JM et al.
Development and validation of a coding framework to identify severe acute toxicity from systemic anti-cancer therapy using hospital administrative data
Boyle JM, Cowling TE, Kuryba A et al.
Survival outcomes associated with completion of adjuvant oxaliplatin-based chemotherapy for stage III colon cancer: A national population-based study.
Boyle JM, Kuryba A, Cowling TE et al.
Validity of chemotherapy information derived from routinely collected healthcare data: A national cohort study of colon cancer patients.
Boyle JM, Kuryba A, Braun MS et al.
Surgical Treatment and Outcomes of Colorectal Cancer Patients During the COVID-19 Pandemic: A National Population-based Study in England.
Kuryba A, Boyle JM, Blake H et al.
Probabilistic linkage without personal information successfully linked national clinical datasets
Blake H, Sharples LD, Harron K et al.
The impact of the first peak of the COVID-19 pandemic on colorectal cancer services in England and Wales: A national survey.
Boyle JM, Kuryba A, Blake H et al.
One-year mortality of colorectal cancer patients: development and validation of a prediction model using linked national electronic data.
Cowling TE, Bellot A, Boyle J, Walker K, Kuryba A, Galbraith S, Aggarwal A, Braun M, Sharples LD, van der Meulen J.
Determinants of variation in the use of adjuvant chemotherapy for Stage III colon cancer in England.
Boyle JM, Kuryba A, Cowling TE et al.
Role of emergency laparoscopic colectomy for colorectal cancer: a population-based study in England.
Vallance AE, Keller DS, Hill J et al.